Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol.

Nakamura T, Takano T, Fukunaga M, Shiraki M, Matsumoto T.

J Bone Miner Metab. 2013 Jul;31(4):417-22. doi: 10.1007/s00774-012-0418-5. Epub 2013 Apr 11.

2.

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.

Matsumoto T, Ito M, Hayashi Y, Hirota T, Tanigawara Y, Sone T, Fukunaga M, Shiraki M, Nakamura T.

Bone. 2011 Oct;49(4):605-12. doi: 10.1016/j.bone.2011.07.011. Epub 2011 Jul 19.

3.

Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis.

Hagino H, Takano T, Fukunaga M, Shiraki M, Nakamura T, Matsumoto T.

J Bone Miner Metab. 2013 Mar;31(2):183-9. doi: 10.1007/s00774-012-0397-6. Epub 2012 Nov 6.

4.

Relationship between the effect of eldecalcitol and serum 25(OH)D level.

Takano T, Kondo S, Saito H, Matsumoto T; Eldecalcitol Study Group.

J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:124-7. doi: 10.1016/j.jsbmb.2013.11.005. Epub 2013 Nov 15.

6.

Eldecalcitol: newly developed active vitamin D(3) analog for the treatment of osteoporosis.

Hagino H.

Expert Opin Pharmacother. 2013 Apr;14(6):817-25. doi: 10.1517/14656566.2013.778825. Epub 2013 Mar 11. Review.

PMID:
23477453
7.

Osteoporosis treatment by a new active vitamin D3 compound, eldecalcitol, in Japan.

Matsumoto T.

Curr Osteoporos Rep. 2012 Dec;10(4):248-50. doi: 10.1007/s11914-012-0116-1.

PMID:
22918710
8.

Eldecalcitol reduces osteoporotic fractures by unique mechanisms.

Kondo S, Takano T, Ono Y, Saito H, Matsumoto T.

J Steroid Biochem Mol Biol. 2015 Apr;148:232-8. doi: 10.1016/j.jsbmb.2015.01.016. Epub 2015 Jan 24.

PMID:
25625663
9.

Eldecalcitol for the treatment of osteoporosis.

Matsumoto T, Endo I.

Drugs Today (Barc). 2012 Mar;48(3):189-96. doi: 10.1358/dot.2012.48.3.1745223. Review.

PMID:
22462038
10.

[Active vitamin D3 analog].

Takata S.

Nihon Rinsho. 2015 Oct;73(10):1701-5. Japanese.

PMID:
26529933
11.

Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.

Matsumoto T, Takano T, Yamakido S, Takahashi F, Tsuji N.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):261-4. doi: 10.1016/j.jsbmb.2010.03.035. Epub 2010 Mar 16.

PMID:
20298784
12.

Eldecalcitol for the treatment of osteoporosis.

Noguchi Y, Kawate H, Nomura M, Takayanagi R.

Clin Interv Aging. 2013;8:1313-21. doi: 10.2147/CIA.S49825. Epub 2013 Sep 27. Review.

13.

Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.

Avenell A, Mak JC, O'Connell D.

Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227. doi: 10.1002/14651858.CD000227.pub4. Review.

PMID:
24729336
14.

Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients.

Ringe JD, Farahmand P, Schacht E.

Rheumatol Int. 2013 Mar;33(3):637-43. doi: 10.1007/s00296-012-2429-x. Epub 2012 Apr 8.

PMID:
22527138
15.

Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.

Reginster JY, Lecart MP, Richy F.

J Rheumatol Suppl. 2005 Sep;76:21-5.

PMID:
16142847
16.

Eldecalcitol: a review of its use in the treatment of osteoporosis.

Sanford M, McCormack PL.

Drugs. 2011 Sep 10;71(13):1755-70. doi: 10.2165/11206790-000000000-00000. Review. Erratum in: Drugs. 2011 Dec 24;71(18):2390.

PMID:
21902297
18.

Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.

Matsumoto T, Takano T, Saito H, Takahashi F.

Bonekey Rep. 2014 Mar 5;3:513. doi: 10.1038/bonekey.2014.8. eCollection 2014. Review.

19.

Eldecalcitol normalizes bone turnover markers regardless of their pre-treatment levels.

Shiraki M, Saito H, Matsumoto T.

Curr Med Res Opin. 2012 Sep;28(9):1547-52. Epub 2012 Aug 23.

PMID:
22794117
20.

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.

Ringe JD, Faber H, Fahramand P, Schacht E.

J Rheumatol Suppl. 2005 Sep;76:33-40.

PMID:
16142849

Supplemental Content

Support Center